Moderna covid-19 vaccine found 94.5% effective at preventing coronavirus3 min read . Updated: 16 Nov 2020, 05:36 PM IST
- Moderna Inc became the second US company to release data from a large study of its experimental vaccine
- Moderna's first analysis was based on 95 cases of COVID-19, 90 of which received a placebo with 5 receiving the vaccine
For the second time this month, a more positive news comes from another Covid vaccine candidate. Moderna Inc today announced that the independent NIH-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of mRNA-1273, its vaccine candidate against COVID-19, has shown that the company's experimental vaccine is 94.5% effective in preventing novel coronavirus.
Select your Category